Machine signal
Active cluster buy — 6 distinct insiders, $136K, window ends Jul 27, 2026.
Figures computed from official regulatory filings — .
Analysttarget 8.33 USD (+467%) · consensus 4.67/5 · 3 buy · 0 hold · 0 sell
Ownershipinsiders 31.13% · institutions 20.12% · short 0.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for OKYO Pharma Ltd only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
13 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Patil Rajkumar V. | Buy | $5K | conv 57Cluster |
| SEC |
| Mantelli Flavio | Buy | $28K | conv 84ClusterFirst in 12mo | SEC |
| Dempsey Robert John | Buy | $23.1K | conv 89ClusterFirst in 12mo | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $35K | conv 30 | SEC |
| JACOB GARY Strack record | Buy | $4.9K | conv 56ClusterFirst in 12mo | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $32.6K | conv 40Cluster | SEC |
| BRANCACCIO JOHN Ptrack record | Buy | $7.4K | conv 53ClusterFirst in 12mo | SEC |
| Dempsey Robert John | Award | $23.1K | SEC |
| CERRONE GABRIELE Mtrack record | Award | $32.6K | SEC |
| JACOB GARY Strack record | Award | $4.9K | SEC |
| Mantelli Flavio | Award | $28K | SEC |
| Denoyer Bernard | AwardD (derivative) | $6.5K | SEC |
| Simon Willy Jules | AwardD (derivative) | $12K | SEC |
| BRANCACCIO JOHN Ptrack record | AwardD (derivative) | $12K | SEC |
| CERRONE GABRIELE Mtrack record | Award | $516K | SEC |
| Shah Keeren Rameshchandra | AwardD (derivative) | $74K | SEC |
| CERRONE GABRIELE Mtrack record | Other | $749.2K | SEC |
| CERRONE GABRIELE Mtrack record | Other | $105.1K | SEC |
| BRANCACCIO JOHN Ptrack record | Buy | $25K | conv 42First in 12mo | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $464K | conv 38Unusual size | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $150K | conv 57 | SEC |
| JACOB GARY Strack record | Buy | $50K | conv 36First in 12mo | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $96.8K | conv 20 | SEC |
| CERRONE GABRIELE Mtrack record | Buy | $97.5K | conv 11 | SEC |